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Abstract
Over four million individuals in the United States
currently suffer from Alzheimer's disease (AD), a
devastating disorder of progressive dementia.
Within the next several decades, AD is expected to
affect over 22 million people globally. AD can only
be definitively diagnosed by postmortem examination. Thus, investigation into the specific pathogenesis of neuronal degeneration and death in AD
on a biochemical level is essential for both earlier
diagnosis and potential treatment and prevention
options. Overproduction of amyloid [3-peptide (A[3)
in the brain leads to both free radical oxidative
stress and toxicity to neurons in AD. My undergraduate biochemical studies with regard to AD
explore the various ways in which free radical oxidative stress might contribute to the pathology of
AD. In particular, this review highlights studies
using Af3-precursor mutations in animal models,
and analysis of histone-DNA interactions.

Introduction
Acknowledged as a disease of progressive dementia as early as 1910 by German psychologist Alois
Alzheimer, questions concerning the specifics of
Alzheimer's disease (AD) still plague the scientific
community. With the modern burgeoning of technological approaches in molecular biology and biochemistry, recent research has opened the door to
understanding the basic mechanisms of the disorder (Markesbery, 1997). Over four million individuals in the United States currently suffer from
AD, the fourth leading cause of death in the United
States. Within the next several decades, AD is expected to affect over 22 million people globally
(Butterfield et al., 2001}.
Characterized by the progressive loss of
memory and cognition, major pathological
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hallmarks of the disease include neurofibrillary tangles
(NFTs) , senile (neuritic) plaques (SPs), and synapse
loss (Katzman and Saitoh, 1991) . Amyloid 13-peptide
(AI3), in the form of insoluble fibril deposits, is the
primary component of senile plaques. Currently, AD
can only be definitively diagnosed by postmortem
examination (Varadarajan et al., 2000) . Thus ,
investigation into the specific pathogenesis of neuronal
degeneration and death in AD on a biochemical level
is essential for earlier diagnosis and potential treatment
and prevention options. Known risk factors for AD
include: age, family history of dementia or AD, low
educational level, low linguistic ability during early
stages, and the presence of apolipoprotien E (APO-E)
alleles. Of the APO-E2, APO-E3 , and APO-E4 alleles
present in humans, the APO-E4 allele signifies a
greater incidence of AD (Markesbery, 1997) .
My undergraduate biochemical research with regard to AD explores the various ways in which free
radical oxidative stress might contribute to the pathology of AD. Oxidative stress occurs when there
are more reactive species (radicals) than antioxidant
defenses and repair capacities in a system, such as
the brain. In particular, this review will highlight studies using Al3-precursor mutations in animal models
and analysis of histone-DNA interactions in AD .

Role of A(3 in Oxidative Stress
Our laboratory has proposed that overproduction of
Al3leads to both free radical oxidative stress and toxicity to neurons in AD (Butterfield et al., 2001 ; 2002;
Butterfield and Lauderback, 2002; Varadarajan et al.,
2000). By inserting itself into neuronal membranes,
soluble, aggregated Al3 may induce the formation of
reactive oxygen species and reactive nitrogen species
that lead to lipid peroxidation, protein oxidation, and
protein modification by 4-hydroxy-2-trans-nonenal
(HNE) and acrolein, the reactive products of lipid
peroxidation. Furthermore, Al3-associated free-radical oxidative stress can affect free fatty-acid release
(leading to tau polymerization), disruption of Ca2 +
homeostasis, peroxynitrite formation, inflammatory
response, impairment of mitochondria, and apoptosis.
Al3-associated oxidation may also play a role in the
modification and inhibition of several neuronal and
glial transmembrane transport systems. This includes
ion-motive ATPases, glutamate transporters, glucose
transporters, GTP-coupled transmembrane signaling
proteins, and polyamine transporters; functional loss
in these systems proves destructive to the neurons,
causing cell potential loss, excitotoxic glutamate accumulation, decreased glucose availability, decreased
intracellular communication, and increased neurotox-
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icity (Butterfield et al., 2001 ; 2002; Butterfield and
Lauderback, 2002) .
The amyloid 13-peptide is derived from the normal
processing of the amyloid precursor protein (APP). As
Al3 is a normal soluble component found in plasma
and cerebrospinal fluid, it is suspected that conversion of soluble Al3 into insoluble fibrils may signify a
critical step in disease onset, a sign of overproduction
of Al3 (Varadarajan et al. , 2000). Presenilin-1 (PS1)
appears to cause cleavage of APP, leading to increased
Al3 production (Selkoe, 2001 ). Fibrillar Al3 binding to
receptors increases advanced glycation end-products
to induce oxidative stress and activate microglia (Yan
et al., 1996) .
Neurodegenerative sites in the AD brain correspond to the presence of oxidative stress and increased
Al3 deposits (Hensley et al., 1995) . Given the broad
scope of cellular modifications observed in AD and
the increased Al3 deposits in AD pathology, a free radical oxidation cascade, in which structural and functional alterations would be seen with any protein or
lipid structure attacked by a free radical, is feasible as
a model for neuronal death in AD (Varadarajan et al.,
2000).

Genetic Mutations: Studies of Amyloid
Precursor Protein and Presenilin Genes
Studies in familial AD indicate the central role of Al3 in
AD pathogenesis and the presence of Al3-precursor
mutations; specifically, mutations in the amyloid precursor protein (APP) and presenilin genes lead to overproduction of Al3 and to AD. As in Down's trisomy,
APP is expressed on Chromosome 21; consequently,
Down's syndrome patients exhibit increased Al3 deposits and eventually develop AD (Varadarajan et al.,
2000) . PS1 cleavage of APP could stimulate faulty
processing of Al3 and increased Al3 production (Selkoe,
2001). While the number of sporadic cases of AD overshadows the occurrence of familial AD cases, a common pathogenesis leading to senile plaque and
neurofibrillary tangle formation is postulated for all
forms of AD, corresponding to the similar neuropathologic lesions seen in both familial and sporadic cases.
Therefore, research in familial AD using transgenic
mouse models is applicable to all forms of the disease
(Kurt et al., 2001).
Mice overexpressing mutant human APP genes in
a single transgenic model show evidence of developing fibrillar cerebral Ab deposits similar to the Al3 deposits seen in AD . Cerebral Al3 deposits increase as
well in single transgenic mouse models overexpressing
mutant or wild-type human PS1 proteins. Yet, the single
transgenic models do not show increased Al3 deposits
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until later in adulthood. In APP /PS1 double mutant
models, the mice develop increased fibrillar A[3 deposits in the hippocampus and cerebral cortex earlier
than single transgenic mice (Kurt et al., 2001).

Methods Related to Markers of
Oxidative Stress
Oxidative stress measures for protein oxidation and
lipid peroxidation can be performed on synaptosomes
prepared from brain samples obtained from the mutant mice. Protein oxidation is measured through the
ultra-violet (UV)-Vis, fluorescence, or immunochemical detection of protein carbonyl formation. Free radical attack on susceptible amino acid side chains can
induce protein oxidation to form protein carbonyls,
as can the interaction of proteins with the products of
glycation and glycoxidation, or the products of lipid
peroxidation such as acrolein and 4-hydroxy-2transnonenal (HNE). Protein carbonyls then react with
2,4-dinitrophenylhydrazine to form a protein-bound
hydrazone. This hydrazone is then detected using
spectroscopic or immunochemical methods
(Butterfield et al. , 2001).
Due to the unsaturated bonds in the fatty acid bchain and the high solubility of nonpolar, paramagnetic oxygen in lipid bilayers, like those found in
membranes, oxidative stress is especially dangerous
for lipids. Initiated by a free radical attack on a lipid,
peroxyl radicals are formed when the lipid radical reacts with oxygen. These peroxyl radicals can react
with other lipids to sustain the chain reaction. Many
of the products of lipid peroxidation, such as the unsaturated aldehydes acrolein and HNE, are toxic and
act to induce oxidative modification of nearby proteins. This chain reaction leads to dysfunctional proteins and neuronal death (Butterfield et al., 2002) .
A crude assessment of lipid peroxidation is the
measurement of thiobarbituric acid reactive substances
(TBARS) . Because thiobarbituric acid is highly reactive with non-lipid moieties as well as lipid
peroxidation products, TBARS provide a non-specific
marker of lipid peroxidation in AD brains. TBARS follow a thiobarbituric acid reaction and can be used to
measure molondialdehyde, a secondary product of
lipid peroxidation, through fluorescence studies
(Butterfield et al., 2001) . Because HNE is a reactive
product of lipid peroxidation, HNE adduct formation
measures also provide a marker of lipid peroxidation.
HNE adduct formation is quantified using an
immunoblotting technique to signify protein modification as a secondary product of lipid peroxidation
(Butterfield et al., 2002) .
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Role of Antioxidants
This research will lead to studies to determine if the
administration of various antioxidants, such as Nacetyl cysteine (NAC) has an effect in slowing the
manifestation of degenerative symptoms in oxidative
stress conditions. NAC upregulates glutathione synthesis, providing the limiting amino acid cysteine. Glutathione is present in millimolar levels, is the most
abundant endogenous antioxidant in the brain, and
may act as the first line of defense against oxidative
stress. Our laboratory has previously shown that
intraparitoneal (i.p.) injection of NAC in mice protects against in-vitro hydroxyl radical-, acrolein-, and
peroxynitrite-induced damage (Pocernich et al. , 2000;
2001; Koppal et al., 1999). Furthermore, our
laboratory's studies indicate that i.p. injection of NAC
protects against the Complex 2 inhibitor, 3-Nitropionic
acid, an agent that leads to pathology reminiscent of
Huntington's disease (La Fontaine et al., 2000). From
the mice that have been fed/injected with NAC, future studies will measure protein carbonyl formation,
TBARS, and HNE to determine the relative effect of
an antioxidant in slowing the neurodegeneration in
mutant mice.
Antioxidants such as Vitamin E (a-, b-, g-, d-tocopherols and tocotrienols) also exhibit potential for treatment or prevention options. Vitamin E is the major
chain-breaking antioxidant that protects against lipid
peroxidation at the early stages of free radical attack.
The a-tocopherol form has been shown to reduce neurotoxicity of A[3 in neuronal cell culture (Yatin et al.,
2000). The antioxidant role of a-tocopherol is most
supported in AD, and it may play a role in the inhibition of glutamate-induced cell death (Halliwell, 2001).

DNA Oxidation and Histone Studies
In compacting into chromatin, DNA winds around an
octamer of core histones. These histones, H1, H2A,
H2B, H3, and H4, are rich in lysines in the N-terminus, allowing for close interaction with DNA and adjacent nucleosomes. Lysine is a basic amino acid,
which allows for a strong ionic interaction with DNA
(Butterfield and Lauderback, 2002). Histone acetylation, the substitution of an acetyl group for a hydrogen atom, weakens these interactions, allowing for
the chromatin to open up to transcriptional factors (Li
etal. , 1993).
An imbalance in pro-oxidant over anti-oxidant
factors characterizes an oxidatively stressed system,
such as a brain in AD. As noted above, free radicals
can cause a cascade of oxidative stress that includes
protein oxidation and lipid peroxidation, but DNA
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oxidation also plays a role in the cascade of oxidative
stress in AD. The DNA oxidation marker 8-hydroxy2-deoxyguanosine has been shown to be increased in
mitochondrial and nuclear DNA in AD brain (Mecocci
et al., 1994). His tones, the DNA binding proteins, are
also susceptible to oxidative stress, as has been shown
occurring with hydrogen peroxide treatment (Ullrich
et al., 1999).
HNE, a reactive end product of lipid peroxidation,
can bind to lysine residues by Michael addition to
cause protein modification; Michael addition is an
organic reaction in which a ketone or an aldehyde is
converted to an enolate or an imine in the presence of
a base (Esterbauer et al., 1991). HNE significantly
alters the conformation of cortical synaptosomal membrane proteins, causing dysfunctional proteins
(Subramaniam et al. , 1997}. Studies have shown that
HNE is increased in AD brains (Markesbery and Lovell,
1998) and AD ventricular fluid (Lovell et al., 1997}.
HNE binds to and likely explains the loss of function
of the major glutamate transporter in an AD brain
(Lauderback et al., 2001) . Because it is present in the
AD system and because it causes dysfunctional proteins through oxidative modification, HNE may play
a role in DNA oxidation in AD.
Our laboratory has hypothesized that HNE causes
conformational changes to histones, thus altering their
DNA binding capabilities. DNA damage in AD may
result subsequent to the disruption of histone-DNA
interactions. Furthermore, HNE binding to histones
may block histone acetylation, thereby potentially altering both histone-DNA interactions and transcription factor penetration. These hypotheses are tested
in various ways. Electron paramagnetic resonance
(EPR) spin-labeling shows whether or not HNE binds
to histones and changes their conformation. Disturbing the ionic strength should lessen the ionic histoneDNA interaction; thus, differing the physiological ionic
conditions may show an effect of HNE on histoneDNA interaction. Gel electrophoresis is also used to
analyze the effect of HNE on histone acetylation. A
manuscript describing the results of this study is nearly
ready for submission for peer-review (Drake et al. ,
2003).
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cesses by disrupting lipid structure, protein function,
and DNA binding capabilities. Prevention hope lies
in the use of antioxidants such as Vitamin E and public acknowledgment of the risk factors such as low
education and linguistic capacities. Antioxidants like
N-acetyl cysteine (NAC) also pose a future option for
treatment.
Because of the increasing life span, the effects of
aging and neurodegeneration are becoming more
prominent in the population, with the potential to
evolve into a public health crisis in the near future.
Considerable research currently focuses on possible
treatment pathways and preventive measures for
neurodegenerative diseases like AD.
For the Bibliography, see the on-line version of
this article at www.uky.edu/kaleidoscope/fall2003.

Conclusions
Current research indicates that Alzheimer's disease
(AD) arises due to neurodegeneration promoted by
oxidative stress in the brain and the overproduction
of amyloid ~-peptide (A~) . This oxidative stress can
take the form of protein oxidation, lipid peroxidation,
or DNA oxidation, which confound normal brain pro-
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